Masimo may decide to separate its consumer business with a traditional spinoff, which involves distributing shares of the new ...

After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. The medtech has tapped Katie Szyman for the role, who has been serving as the worldwide ...

which resulted in a temporary injunction on the sale of some of the range towards the end of last year and subsequent removal of the blood oxygen measurement tech on new devices. Masimo sells a ...

Masimo (NASDAQ:MASI) is a global medical technology ... Nasdaq Stockholm Main Market (SEZI), with cross-trading on the New York OTCQX market (SNZZF). More information is available at senzime.com.

Interim CEO Michelle Brennan, who was backed by the activist investor, was appointed chairman of Masimo's board, and Politan founder Quentin Koffey was named the vice-chairman. The new ...

Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator ... Szyman was the right choice given her successful track record of ...

Masimo Trading Up 1.4 % Shares of NASDAQ MASI opened at $172.29 on Friday. The firm has a 50 day moving average price of $169.23 and a two-hundred day moving average price of $140.13. The stock ...